Approval · Notice of Compliance 5266 · 1995
NOLVADEX: Notice of Compliance 5266
Issued September 12, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5266
- Date
- September 12, 1995
- Company
- Zeneca Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revised product monograph
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NOLVADEX | Not yet assigned | — |
Medicinal ingredients
- TAMOXIFEN CITRATE 10 MG per TAB
- TAMOXIFEN CITRATE 20 MG per TAB